Orally administered allyl sulfides from garlic ameliorate murine colitis

Molecular Nutrition and Food Research

Volumn 59, Issue 3, 2015, Pages 434-442

  Fasolino, Ines ^a,b   Izzo, Angelo A ^a   Clavel, Thomas ^b   Romano, Barbara ^a   Haller, Dirk ^b   Borrelli, Francesca ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Colitis; Diallyl disulfide; Diallyl sulfide; Epithelial cells; Food supplement; Garlic; Hydrogen sulfide; IFN ; Inflammatory bowel disease; Nitric oxide

Indexed keywords

ALLIUM SATIVUM; MURINAE; MUS;

ALLYL COMPOUND; ALLYL SULFIDE; BENZENESULFONIC ACID DERIVATIVE; DIALLYL DISULFIDE; DINITROBENZENESULFONIC ACID; DISULFIDE; GAMMA INTERFERON; HYDROGEN SULFIDE; INTERLEUKIN 10; INTERLEUKIN 6; NITRITE; NONSTEROID ANTIINFLAMMATORY AGENT; STAT1 PROTEIN; STAT1 PROTEIN, MOUSE; SULFIDE;

ANIMAL; BODY WEIGHT; CHEMICALLY INDUCED; CHEMISTRY; COLITIS; COLON; DRUG EFFECTS; EPITHELIUM CELL; GARLIC; GENETICS; INFLAMMATORY BOWEL DISEASES; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; METABOLISM; ORAL DRUG ADMINISTRATION; PATHOLOGY;

ADMINISTRATION, ORAL; ALLYL COMPOUNDS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BENZENESULFONATES; BODY WEIGHT; COLITIS; COLON; DISULFIDES; EPITHELIAL CELLS; GARLIC; HYDROGEN SULFIDE; INFLAMMATORY BOWEL DISEASES; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MICE, INBRED ICR; NITRITES; STAT1 TRANSCRIPTION FACTOR; SULFIDES;

EID: 84924004727     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201400347     Document Type: Article

References (34)

1. Khor, B., Gardet, A., Xavier, R. J., Genetics and pathogenesis of inflammatory bowel disease. Nature 2011, 474, 307-317.
2. Cosnes, J., Gower-Rousseau, C., Seksik, P., Cortot, A., Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011, 140, 1785-1794.
3. Molodecky, N. A., Soon, I. S., Rabi, D. M., Ghali, W. A. et al., Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012, 142, 46-54.
4. D'Haens, G., Feagan, B., Colombel, J. F., Sandborn, W. J. et al., Challenges to the design, execution, and analysis of randomized controlled trials for inflammatory bowel disease. Gastroenterology 2012, 143, 1461-1469.
5. Opheim, R., Hoivik, M. L., Solberg, I. C., Moum, B., Complementary and alternative medicine in patients with inflammatory bowel disease: the results of a population-based inception cohort study (IBSEN). J. Crohns Colitis 2012, 6, 345-353.
6. Koning, M., Ailabouni, R., Gearry, R. B., Frampton, C. M. et al., Use and predictors of oral complementary and alternative medicine by patients with inflammatory bowel disease: a population-based, case-control study. Inflamm. Bowel Dis. 2013, 19, 767-778.
7. Borrelli, F., Capasso, R., Izzo, A. A., Garlic (Allium sativum L.): adverse effects and drug interactions in humans. Mol. Nutr. Food Res. 2007, 51, 1386-1397.
8. Rahman, K., Garlic and aging: new insights into an old remedy. Ageing Res. Rev. 2003, 2, 39-56.
9. Block, E., The chemistry of garlic and onions. Sci. Am. 1985, 252, 114-119.
10. Chiang, Y. H., Jen, L. N., Su, H. Y., Lii, C. K. et al., Effects of garlic oil and two of its major organosulfur compounds, diallyl disulfide and diallyl trisulfide, on intestinal damage in rats injected with endotoxin. Toxicol. Appl. Pharmacol. 2006, 213, 46-54.
11. Aviello, G., Abenavoli, L., Borrelli, F., Capasso, R. et al., Garlic: empiricism or science? Nat. Prod. Commun. 2009, 4, 1785-1796.
12. Harisa, G. E., Abo-Salem, O. M., El-Sayed, el-S. M., Taha, E. I. et al., L-arginine augments the antioxidant effect of garlic against acetic acid-induced ulcerative colitis in rats. Pak. J. Pharm. Sci. 2009, 22, 373-380.
13. Kuo, C. H., Lee, S. H., Chen, K. M., Lii, C. K. et al., Effect of garlic oil on neutrophil infiltration in the small intestine of endotoxin-injected rats and its association with levels of soluble and cellular adhesion molecules. J. Agric. Food Chem. 2011, 59, 7717-7725.
14. Amagase, H., Petesch, B. L., Matsuura, H., Kasuga, S. et al., Intake of garlic and its bioactive components. J. Nutr. 2001, 131, 955S-962S.
15. Wallace, J. L. Physiological and pathophysiological roles of hydrogen sulfide in the gastrointestinal tract. Antioxid. Redox Signal. 2010, 12, 1125-1133.
16. Iciek, M. B., Kowalczyk-Pachel, D., Kwiecień, I., Dudek, M. B., Effects of different garlic-derived allyl sulfides on peroxidative processes and anaerobic sulfur metabolism in mouse liver. Phytother. Res. 2012, 26, 425-431.
17. Izzo, A. A., Capasso, R., Aviello, G., Borrelli, F. et al., Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice. Br. J. Pharmacol. 2012, 166, 1444-1460.
18. Holzer, P., Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system. Pharmacol. Ther. 2011, 131, 142-170.
19. Borrelli, F., Fasolino, I., Romano, B., Capasso, R. et al., Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease. Biochem. Pharmacol. 2013, 85, 1306-1316.
20. Massa, F., Marsicano, G., Hermann, H., Cannich, A. et al., The endogenous cannabinoid system protects against colonic inflammation. J. Clin. Invest. 2004, 113, 1202-1209.
21. Aviello, G., Borrelli, F., Guida, F., Romano, B. et al., Ultrapotent effects of salvinorin A, a hallucinogenic compound from Salvia divinorum, on LPS-stimulated murine macrophages and its anti-inflammatory action in vivo. J. Mol. Med. (Berl) 2011, 89, 891-902.
22. Ruiz, G., Peña, P., de Ory, F., Echevarría, J. E., Comparison of commercial real-timePCR assays for quantification of Epstein-Barr virus DNA. J. Clin. Microbiol. 2005, 43, 2053-2057.
23. Pfaffl, M. W., A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29, e45.
24. Romano, B., Fasolino, I., Pagano, E., Capasso, R. et al., The chemopreventive action of bromelain, from pineapple stem (Ananas comosus L.), on colon carcinogenesis is related to antiproliferative and proapoptotic effects. Mol. Nutr. Food Res. 2014, 58, 457-465.
25. Zhu, Y. Z., Wang, Z. J., Ho, P., Loke, Y. Y. et al., Hydrogen sulfide and its possible roles in myocardial ischemia in experimental rats. J. Appl. Physiol. (1985). 2007, 102, 261-268
26. Calixto, J. B., Campos, M. M., Otuki, M. F., Santos, A. R., Anti-inflammatory compounds of plant origin. Part II. modulation of pro-inflammatory cytokines, chemokines andadhesion molecules. Planta. Med. 2004, 70, 93-103.
27. Lee, H. S., Lee, C. H., Tsai, H. C., Salter, D. M., Inhibition of cyclooxygenase 2 expression by diallyl sulfide on joint inflammation induced by urate crystal and IL-1beta. Osteoarthritis Cartilage 2009, 17, 91-99.
28. Kalayarasan, S., Prabhu, P. N., Sriram, N., Manikandan, R. et al., Diallyl sulfide enhances antioxidants and inhibits inflammation through the activation of Nrf2 against gentamicin-induced nephrotoxicity in Wistar rats. Eur. J. Pharmacol. 2009, 606, 162-171.
29. Woo, H. M., Kang, J. H., Kawada, T., Yoo, H. et al., Active spice-derived components can inhibit inflammatory responses of adipose tissue in obesity by suppressing inflammatory actions of macrophages and release of monocyte chemoattractant protein-1 from adipocytes. Life Sci. 2007, 80, 926-931.
30. Blackler, R. W., Motta, J. P., Manko, A., Workentine, M. et al., Hydrogen sulfide protects against nsaid-enteropathy through modulation of bile and the microbiota. Br. J. Pharmacol. 2014. doi: 10.1111/bph.12961.
31. Artis, D., Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat. Rev. Immunol. 2008, 8, 411-420.
32. Hoermannsperger, G., Clavel, T., Hoffmann, M., Reiff, C. et al., Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria: impact on chronic inflammation. PLoS One 2009, 4, e4365.
33. Medani, M., Collins, D., Docherty, N. G., Baird et al., Emerging role of hydrogen sulfide in colonic physiology and pathophysiology. Inflamm. Bowel Dis. 2011, 17, 1620-1625.
34. Chan, M. V., Wallace, J. L. Hydrogen sulfide-based therapeutics and gastrointestinal diseases: translating physiology to treatments. Am. J. Physiol. Gastrointest. Liver Physiol. 2013, 305, G467-G473.